In postmenopausal osteoporotic women, changing from teriparatide to denosumab benefits bone mineral density (BMD) but switching from denosumab to teriparatide may result in bone loss, according to new research.
Reuters Health Information …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
